Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Arranta Bio, a 6-month-old contract development and manufacturing organization, has raised $82 million from investors including Thermo Fisher Scientific and the private equity firm Ampersand Capital Partners. Arranta plans to develop and commercialize therapies for customers targeting diseases linked to the human microbiome. It expects to open late-clinical and commercial-ready capacity in Watertown, Massachusetts, by mid-2020. Separately, Arranta has formed a partnership in which it will provide Thermo Fisher with gene therapy materials.
This article has been sent to the following recipient: